Jun 22, 2021 / 04:00PM GMT
Elliot Wilbur - Raymond James - Analyst
Good afternoon. Welcome to the ANI Pharmaceuticals presentation and update at Raymond James Annual Health and Human Innovation Conference. My name is Elliot Wilbur. I'm the coverage analyst on ANI and covering the specialty pharmaceutical space for Raymond James. For those of you not familiar with ANI Pharma, it's a Company with its foundation built in the generics industry but has rapidly pivoted towards repositioning itself as a US-focused biopharma story with multiple growth platforms, spanning both the brand and generic drug sectors.
Providing us with an update on recent developments is the Company's Chief Executive Officer, Nikhil Lalwani; and we also are joined by the Company's Chief Financial Officer, Steve Carey. So with that, the floor is yours, Nikhil.
Nikhil Lalwani - ANI Pharmaceuticals, Inc. - President and CEO
Thank you, Elliot. I'll go ahead and share my screen. Can you see it?
Elliot Wilbur - Raymond James - Analyst
Yes, we can see it. You're good to go,
ANI Pharmaceuticals Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers